期刊文献+

环孢素对正常人PBMCs产生IFN-γ的抑制作用 被引量:2

Inhibitory Effect of Ciclosporine on Production of IFN-γ by Human PBMCs
下载PDF
导出
摘要 【目的】探讨在不同刺激条件下,环孢素(ciclosporine,CsA)对正常人外周血单个核细胞(PBMCs)γ-干扰素(interferon-gamma,IFN-γ)的产生,以及对细胞亚群的影响。【方法】PBMCs在抗CD3单克隆抗体(anti-CD3)、抗CD3和抗CD28(anti-CD28)单克隆抗体、IL-12(Th1细胞分化因子)刺激的情况下或在混合淋巴细胞反应中,观察CsA对IFN-γ产生和Th1细胞分化的影响。同时使用流式细胞仪,在单个细胞水平上评价CsA对T淋巴细胞表面活化分子CD25及细胞内细胞因子IFN-γ和IL-2产生的影响。【结果】CsA对由不同条件诱导产生的IFN-γ,均表现为剂量依赖性抑制关系。此外,CsA抑制IL-12诱导的Th1分化。进一步研究结果表明,CsA可抑制CD4+和CD8+T细胞IFN-γ的表达。【结论】CsA剂量依赖性抑制T淋巴细胞的活化,抑制CD4+、CD8+T淋巴细胞产生IFN-γ和Th1细胞的分化,其抑制机理可能与细胞的活化有关。 [Objective] To evaluate the effect of ciclosporine (CsA) on the production of IFN-γ by peripheral blood mononuclear cells (PBMCs) and on the cell subsets following stimulation under different culture condition.[Methods]PBMCs were prepared and cultured either with anti-CD3 alone, anti-CD3 plus anti-CD28, IL-12 or mixed leukocyte culture (MLC) in the presence or absence of CsA at different concentration. After stimulation for 3 or 5 days, the level of IFN-γ in the culture supernatant was assayed by ELISA. In addition, the cultured cells were harvested, restimulated and stained for the expression of intracellular cytokines. The frequency of IFN-γ-producing and IL-2-producing cells by CD4+ and CD8+ T cells was examined at a single cell level by flow cytometric analysis.[Results]After stimulation at different culture conditions, T cells produced high levels of IFN-γ. CsA inhibited INF-γ production in a dose dependent manner. The inhibitory effects of CsA on IL-12-induced differentiation of Th1 cells and IL-12 responsiveness were observed as well. Further analysis indicated that CsA suppressed IFN-γ expression by both CD4+ and CD8+ T cells.[Conclusion] CsA inhibits the production of IFN-γ by both CD4+ and CD8+ T cells and the differentiation of Th1 cells via a mechanism of suppression of early T cell activation.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2005年第4期366-370,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家自然科学基金(创新群体)资助项目(30321004) 国家重点基础研究发展规划(973)基金资助项目(2001CB510007)
  • 相关文献

参考文献17

  • 1Gallagher MP, Hall B, Craig J, et al. A randomized controlled trial of cyclosporine withdrawal in renaltransplant recipients: 15-year results[J]. Transplantation,2004, 78(11): 1653-60.
  • 2Bolwell B, Sobecks R, Pohlman B, et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation[J].Bone Marrow Transplant, 2004, 34(7):621-5.
  • 3Alvarez F. Treatment of autoimmune hepatitis: Current and future therapies [J]. Curr Treat Options Gastroenterol, 2004, 7(5):413-20.
  • 4Kircher B, Latzer K, Gastl G, et al. Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies[J]. Clin Exp Immunol, 2003,134(3):426-30.
  • 5Matsue H, Yang C, Matsue K, et al. Contrasting impacts of immunosuppressive agents (rapamycin,FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation[J]. J Immunol, 2002,169(7):3555-64.
  • 6Tajima K, Amakawa R, Ito T, et al. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets [J]. Immunology, 2003, 108(3):321-8.
  • 7杨滨燕,朱兆玲,吴长有.CD4^+T细胞的分裂与表面标志和细胞因子产生相关性的探讨[J].中国免疫学杂志,2004,20(9):587-590. 被引量:16
  • 8Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity [J]. Nat Rev Immunol, 2003, 3(2):133-46.
  • 9Shirota H, Gursel M, Klinman DM. Suppressive oligodeoxynucleotides inhibite Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling [J].J Immunol, 2004, 173(8):5002-7.
  • 10Wu CY, Wang X, Massimo G, et al. IL-12 receptor beta 2 (IL-12Rβ2)- deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites [J]. J Immunol,2000,165(11): 6221-8.

二级参考文献10

  • 1GettAV,HodgkinPD.CelldivisionregulatestheTcellcytokinereper toire,revealingamechanismunderlyingimmuneclassregulation[].Proceedings of the National Academy of Sciences of the United States of America.1998
  • 2HuH,HustonG,DusoDetal.CD4+Tcelleffectorscanbecomememorycellswithhighefficiencyandwithoutfurtherdivision[].Na tureImmunology.2001
  • 3SederRA,GazzinelliR,SherAetal.Interleukin12actsdirectlyonCD4+Tcellstoenhanceprimingforinterferongproductionanddimin ishesinterleukin4inhibitionofsuchpriming[].Proceedings of the National Academy of Sciences of the United States of America.1993
  • 4TrinchieriG.Interleukin12andtheregulationofinnateresistanceandadaptiveimmunity[].NatureRevImmunology.2003
  • 5WuCY,WangX,GadinaMetal.IL 12receptorβ2(IL 12Rβ2) deficientmicearedefectiveinIL 12 mediatedsignalingdespitethepresenceofhighaffinityIL 12bindingsites[].JImmunol.2000
  • 6WuCY,KirmanJR,RotteMJetal.DistinctlineagesofTh1cellshavedifferentialcapacitiesformemorycellgenerationinvivo[].NatureImmunology.2002
  • 7DuttonRW,BradleyLM,SwainSL.Tcellmemory[].AnnRevIm munol.1998
  • 8Mosmann TR,Coffman RL.Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties[].Annual Review of Immunology.1989
  • 9Abbas AK,Murphy KM,Sher A.Functional diversity of helper T lymphocytes[].Nature.1996
  • 10Sallusto F,Lenig D,Forster R,et al.Two subsets of memory T lymphocytes with distinct homing potentials and effector functions[].Nature.1999

共引文献15

同被引文献15

  • 1吴长有.Th17细胞:一种新的效应CD4^+T细胞亚群[J].细胞与分子免疫学杂志,2006,22(6):695-697. 被引量:36
  • 2Lee S S, Kim H, Wang N S et al. A pharmaeokinetic and safety evaluation of an episcleral eyelosporine implant for potential use in high-risk keratoplasty rejection [ J ]. Invest Ophthalmol Vis Sci, 2007 ; 48 ( 5 ) : 2023-2029.
  • 3Alvarez F. Treatment of autoimmune hepatitis:Current and future therapies [J]. Curr Treat Options Gastroenterol,2004;7(5):413-420.
  • 4Gallagher M P, Hall B, Craig J et al. A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15 year results [ J]. Transplantation,2004; 78( 11 ) : 1653-1660.
  • 5Harrington L E, Mangan P R, Weaver C T. Expanding the effector CD4 T- cell repertoire: the Th17 lineage[J]. Curr Opin Immunol,2006; 18(3): 349-356.
  • 6Huang W T, Na L, Fidel P Let al. Requirement of interleukin-17A for systemic anti-candida albicans host defense in mice [J]. J Infect Dis, 2004; 190(3) :624-631.
  • 7Zhou M H,Yang B Y,Ma R H et al.Memory Th-17 cells specific for C. albicans are persistent in human peripheral blood[ J]. Immunol Lett, 2008; 118(1) :72-81.
  • 8Zhang C, Zhang J Y, Yang B Yet al. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis [ J ]. Cytokine, 2008 ; 42 (3) : 345-352.
  • 9Wu C Y,Wang X,Gadina M et al.IL-12 receptor beta 2 ( IL-12Rβ2)- deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites[ J]. J Immunol,2000;165 (11 ): 6221-6228.
  • 10苏涛,张培红,徐泽锋,陈辉树,秦铁军,张悦,张宏丽,方力维,潘丽娟,肖志坚.原发性骨髓增生异常综合征伴骨髓纤维化患者的临床特征和预后分析[J].中华血液学杂志,2012,33(5):378-382. 被引量:7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部